L13 Colonic Cancer Flashcards

1
Q

At what age does the risk of colon cancer begin?

A

40-45 (Risk Doubles w/ each succeeding decade)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Percent of the Population at risk of colon cancer?

Contribution of genetics/Environment to risk?

A

5%

20% genetic, 80% environmental (lifestyle, diet => influences microbiome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Risk factors of Colon Cancer?

A
  • Processed meat (WHO group 1 carcinogen)
  • Red meat (group 2A –probable)
  • Cigarettes
  • Alcohol
  • High BMI
    *Sulfur-Metabolizing Microbiome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Protective factors for colon cancer?

A

*Healthy diet
*Physical activity
*Medication: HRT, NSAIDs

GOAL=Diverse microbiome with short-chain fatty acid-producing anaerobes & fiber-fermenting bacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Clinical Presentation of Colorectal Cancer?

A
  • Change of bowel habit
  • Mucus or blood PR
  • Anemia (Iron deficiency)
  • Pain if an obstruction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Investigations for Colorectal Cancer?

A

Physical Rectal Exam
Fecal Occult Blood (FIT Positive 50% adenoma, 50% Carcinoma)
Endoscopy (Screening Programs)
Biopsy
CT Collagraphy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

5 year survival of Various stages of Colorectal Cancer?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

_________________________________:
Left-Sided, Benign Neoplastic Polyps of the Rectosigmoid
Two Types (based on cytoplasmic Differentiation):
________________________
________________________
Usually _________ diameter.
Usually affects ________________

A

Hyperplastic Polyp:
Left-Sided, Benign Neoplastic Polyps of the Rectosigmoid
Two Types (based on cytoplasmic Differentiation):
Micro-vesicular (most common)
Goblet cell rich
Usually < 5mm in diameter.
Usually middle to old age ( mean 62 years)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

__________________________
Right-sided Benign Lesion of the colon responsible for ______of CRCs
Risk of developing ____________________________ within the polyp.
→ should be removed where possible.
Usually _______________ in diamter
Associated with ________________________________

A

*Sessile Serrated Lesion (SSL): *
Right-sided Benign Lesion of the colon responsible for 30% of CRCs
Risk of developing high grade dysplasia and carcinoma within the polyp.
→ should be removed where possible.
Usually *large (typically > 10mm) *
SSLs associated with synchronous advanced colorectal neoplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Sessile Serrated Lesion (SSL) with _________ carry an increased & accelerated risk of progression

A

Sessile Serrated Lesion (SSL) with dysplasia carry an increased & accelerated risk of progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Evidence fot Adenoma-Carcinoma Sequence?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Risk of development of Malignanacy in Adenomas?

A
  • Size > 1cm (large size is the most important risk factor)
  • Multiple adenomas
  • High-grade dysplasia
  • Prominent villous component
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Most common type of colorectal cancer and its location?

A

Adenocarcinoma (98%)

Rectosigmoid most common location

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Colon Cancer with 1 metastatic lesion, can be resected, survival rate high

A

Oligometastatic

17
Q

Risks/Manifestations of Cancer in Ulcerative Colitis

A

<1% of all Colon Cancer
Risks
a) > 8-10yrs
b) pan-colitis
Flat pre-malignant dysplasia
May be multifocal
Aggressive
Advanced stage at diagnosis

18
Q

Examples of Colorectal Cancer Syndromes and their inheritance?

19
Q

Inheritance/Pathogenesis of Lynch Syndrome?

A

Autosomal Dominant Inheritance
Usually inherited, can be new mutation

Most common form of familial Colorectal Cancer (3% CRC)
Caused by mutation in mismatch repair gene (MMR) leading to microsatellite instability

20
Q

Most common form of familial Colorectal Cancer?

A

Lynch Syndrome - 3% CRC

21
Q

Inheritance/Pathogenesis/Epidemiology/Manifestations of Lynch Syndrome?

A

Familial Adenomatous Polyposis:
Autosomal Dominant Inheritance
Loss of APC Gene!!- APC targets Beta-catenin for degradation (Wnt pathway)
=> Colorectal adenocarcinomas < 40 years old

> 100 polyps predominantly in the large intestine (typically 1000s of polyps!!)
Extra-intestinal manifestations

Duodenal carcinoma desmoid tumour (fibromatosis) commonest cause of death

22
Q

Commonest cause of death for Pts. with Familial Adenomatous Polyposis?

A

Duodenal carcinoma desmoid tumour (fibromatosis)

23
Q

Inheritance/ Epidemiology/Manifestations of MYH-Associated Polyposis

A

Autosomal recessive inheritance
Mean age of cancer diagnosis = 50 years old
Penetrance near 100%.
Clinically similar to attenuated FAP (30% of NON-APC Familial Adenomatous Polyposis)

24
Q

Inheritance/Epidemiology/Manifestations of Serrated Polyposis?

A

Unknown Genetics

Develop multiple serrated polyps:
20 serrated polyps (Hyperplastic or SSLs) of any size distributed throughout the colon

Up to 50% may develop colorectal cancer

25
Inheritance/ Epidemiology/Pathogenesis of Juvenile Polyposis
Autosomal dominant inheritance (Incomplete Penetrance) Half of cases are de novo (No family history) Average age of onset is 18 years old!! Germline mutations involve the TGF-β signal transduction pathway –SMAD- 4 –BMPR1A Significant Risk of Colorectal Cancer
26
Diagnostic Criteria for Juvenile Polyposis??
> 3-5 Juvenile polyps in the colorectum. or Juvenile polyps throughout the GI tract. or Juvenile polyp + family history.
27
Why is Microsatellite Instable (MSI) Status Important for colorectal cancer?
*Prognostic Indicator:*MSI+ CRC patients have a better prognosis compared with Microsatellite Stable (MSS) *Therapeutic biomarker* –Benefit from FOLFOX –Stage IV benefit from Immune checkpoint inhibitors *Diagnosis of Lynch syndrome*
28
29
Mechanism of Erbitux in Colorectal Cancer treatment?
Erbitux blocks EGFR signal transduction and inhibits intracellular signaling The anti-tumor effects mediated by EGFR blockade require normal/wild-type KRAS & are bypassed by mutated KRAS, which signals WITHOUT prior EGFR-mediated signaling rendering Eribitux innefective